Dr Jhaveri explains her thoughts on sequencing ADCs in the treatment of triple-negative breast cancer.
Dr Andre on Survival Results From the SOLSTICE Trial in mCRC
Post-hoc Analysis Showed Maintenance Niraparib Provides Additional Antitumor Activity in Advanced Ovarian Cancer
Niraparib as Second-line Maintenance Demonstrates Real-world OS Benefit in Recurrent Ovarian Cancer
Eftilagimod Alpha Plus Pembrolizumab Generates Responses, Safety in Metastatic HNSCC